GlobeNewswire by notified

RevoluGROUP Canada Inc. Announces $1 Million Private Placement, Ex-CEO Marshall Outreach to Bernard Lonis Company Chairman


VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2), (Munich: A2PU92) (the "Company") announces a non-brokered private placement of up to 20,000,000 units at a price of $0.05 each, to raise gross proceeds of up to $1,000,000. Each unit will consist of one common share and one warrant (each, a "Warrant") exercisable to purchase one additional common share at a price of $0.10 each for a period of one (1) year from the date of issuance. The expiry of the Warrants may be accelerated at the sole discretion of the Company by written notice if the closing price for the Common Share on the TSX Venture Exchange shall be equal to or greater than CAD $0.15 for a minimum of ten (10) consecutive trading days. Ex-CEO Steve Marshall could satisfy a sizable lead order for the Private Placement, pending the successful approval and completion of the subsequent commitments as specified below.

The private placement is subject to TSX Venture Exchange approval, and all securities are subject to a four-month-and-one-day hold period. Finder fees may be payable in connection with the private placement, all in accordance with the policies of the TSX Venture Exchange.

Ex-CEO Marshall Outreach to Bernard Lonis Chairman

Over the weekend of the 4th and 5th of May 2024, in what was a surprise call, the Company's ex-CEO, Mr. Steve Marshall, reached out to the Company Chairman, Mr. Lonis. Shareholders should note that Mr. Marshall remains a significant shareholder of the Company. Over the two days, the two spoke for almost 3 hours about numerous matters, including the sudden resignation of the Company CEO, Mr. McMillan.

About Steve Marshall Ex-CEO of RevoluGROUP Canada Inc.

The following paragraph is exclusively for shareholders who joined the Company after 28th July 2023. Mr. Marshall served as CEO of the Company for over seven years, from March 21st, 2016, to July 28th, 2023. He is primarily known as the visionary, architect, and principal strategic investor in what became the Company's international NeoBANK infrastructure, having taken on the challenging role as CEO of what was in 2016 a defunct Canadian TSX Venture listed mining shell with approximately $CA 17 million shareholder debt. During Mr. Marshall's tenure, the Company attained a market capitalization of over 100 million Canadian dollars, obtained EU Central Bank PSD2 financial licenses, Central Bank PSD2 Branch Rights Granted in 27 EU Countries, Canadian FinTRAC, Florida, USA, MSB license, Visa Inc. partnership, along with too many other notable achievements to list here but are disclosed comprehensively on Sedar and under the news section of our corporate website. As a notable testament to Marshall's tenure, in February 2023, the TSX Venture Canadian Stock Exchange inducted RevoluGROUP into the distinguished Top 50 publicly listed Companies, situating the Company within the prestigious top 3% of all 1713 publicly traded Canadian companies. Sadly, shortly after that, multiple physicians instructed Mr. Marshall to reduce stress urgently. Ultimately, his rapidly deteriorating health forced him to step down as CEO in July 2023 due to prolonged and persistent pulmonary complications, including numerous hospitalizations, diagnosed during Magnetic Resonance Imaging (MRI) tests in August 2023 with a final prognosis of impaired lung function due to coronary artery calcium build-up linked to oxidative stress and systemic inflammation, causal in the pathogenesis of atherosclerosis. Thankfully, in recent times, with the help of top physicians, Mr. Marshall has gained significant ground via intensive treatment allied to a strict regimen.

Mr Marshall's Three-Step Proposal to the Board of Directors

During the conversation with Chairman Bernard Lonis, Mr. Marshall conveyed his openness to considering resuming a possible leadership role at RevoluGROUP, including possibly participating as a lead participant in the Company's today-announced private placement. However, Marshall's strict terms discussed for almost 3 hours and meticulously compiled during the call would require not only board ponderance and a signed Board of Directors resolution, essentially acquiescing to Mr. Marshall's entire obligations, but, more importantly, also include seeking written external sourced Canadian Regulatory approval from both Canadian Capital Markets regulatory bodies before he would consent to consider reinstatement, private placement investment or eventual recommencement of active executive management duties. In short, Mr. Marshall has made it clear that he will not invest in the private placement nor consider any executive function until the key phases below are entirely approved and ratified satisfactorily:

Phase 1

  • The RevoluGROUP Canada Inc., every board of directors member, agrees unanimously to a compensation package exclusively via issuing corporate shares for debt for an initial period of six calendar months. The monthly stipend will also be reduced to 1000 Canadian dollars for each board member during the prescribed initial term. The incoming interim CEO would lead by example, assuming the cited compensation.
  • The Company obtains Canadian Regulatory approval from BOTH Capital Markets regulatory bodies approving in writing a proposed unconstrained reassumption of Marshall as interim CEO, along with an equally positively sanctioned tenure of Mr. McMillan, all from a purely regulatory standpoint. These provisions ensure that the CEO can immediately concentrate on resolving urgent corporate matters, fomenting a clear path forward, and securing financing, including shareholder value, rather than attending to extraneous issues that can be time-consuming, detrimental to shareholders, stressful and unrelated to bringing the desired rapid positive corporate outcomes and subsequent shareholder value.
  • The RevoluGROUP Canada Inc. board of directors agrees to take immediate measures to ensure expenditure reductions at RevoluPAY EP S.L. to the point that the wholly-owned subsidiary in Barcelona will become cash flow positive through its autonomous operations by November, 30th, 2024. The intent is to stem the repeated outflow of capital from the parent into the RevoluPAY S.L subsidiary while concentrating on core revenue sources to achieve break-even at RevoluPAY S.L Barcelona.
  • The RevoluGROUP Canada Inc. board of directors agrees unanimously to permit the interim CEO to solicit at least 40 supplementary state MSB licenses in the United States and pursue the upcoming regulatory requirements for Open Banking licensing in Canada. The intent is to reconfigure corporate objectives towards an amplified presence in the world's largest economy—the United States.
  • RevoluGROUP Canada Inc., under Marshall's request, the board of directors agrees unanimously to admit the return of Gavin McMillan to collaborate alongside Marshall in a yet-to-be-disclosed role to pursue those above-denoted North American corporate ambitions.

Phase 2

Presuming every point imposed in Phase 1 is accomplished, Steve Marshall will reassume the role of interim CEO pending the outcome of Phase 3. Furthermore, to resolve the Company's contemporary financial distress, Marshall would immediately place a lead order in the current corporate financing, including a good faith partial first-tranche closing of said private placement.

Phase 3

A public shareholder vote should be held before Marshall even considers accepting a return to the role of definitive Corporate CEO. Marshall does not wish the board to impose a renewed tenure upon shareholders without their majority blessing and tallied vote being public information. Furthermore, presuming many shareholders are still those who invested during Marshall's extended 7-year tenure, those shareholders should be given the option to vote for Marshall's return in support of his professional legacy at RevoluGROUP. If, conversely, Marshall does not prevail in the proposed shareholder vote, he agrees to assist the Company as interim CEO until a new CEO is named.

Concluding statement from Mr. Lonis

We are hopeful about Mr. Marshall's surprise proposal and his familiar, forthright demeanor during our call. However, I must state there can be no guarantee Marshall will return as interim CEO, invest in the current private placement, or return in any capacity at RevoluGROUP Canada Inc. unless all of his demands are met. The board and I must discuss these this week. Marshall told me he is traveling extensively but agreed to call me back at 5 pm CET on Friday, the 10th of May, to obtain our answers. As the board's chairman, I wish to assure shareholders that I will discuss Mr. Marshall's demands with my board colleagues and ask our corporate counsel to immediately reach out to BOTH Capital Markets regulatory bodies as stated above.

Links Used in this News Release.

Steve Marshall Resignation 28th July 2023 -
European PSD2 Banking License Granted -
Canadian FinTRAC -
Central Bank PSD2 Branch Rights Granted in 27 EU Countries -
Florida USA MSB Financial License -
Visa Inc Partnership -

About RevoluPAY®

The Company's flagship Neobanking technology is RevoluPAY®, the Apple and Android multinational payment app. Conceived entirely in-house, RevoluPAY features proprietary, sector-specific technology of which the resulting source code is the Company's intellectual property. RevoluPAY's built-in features include Remittance Payments, Forex, Crypto-to-fiat exchange, Retail and Hospitality payments, Real Estate Payments, pay-as-you-go phone top-ups, Gift Cards & Online Credits, Utility Bill payments, Gaming Credits, Leisure payments, Travel Payments, etc. RevoluPAY is aimed squarely at the worldwide multi-billion dollar Open Banking sector, cross-border forex payments, and + $595 billion family remittance market. RevoluPAY® is operated by the European wholly-owned subsidiary RevoluPAY EP S.L situated in Barcelona. RevoluPAY is a licensed United States MSB, Canadian FINTRAC, and European PSD2 payment institution 6900 under the auspices of E.U. Directive 2015/2366 with E.U. 27 Country Passporting and official issuer of Visa® Cards and authorized Visa® Affiliate Member. RevoluGROUP Canada Inc. controls five wholly-owned subsidiaries on four continents.

About RevoluGROUP Canada Inc.:

RevoluGROUP Canada Inc. is a multi-asset, multidivisional, publicly traded Canadian Company deploying advanced technologies in; Banking, Mobile Apps, Money Remittance, Cross-Border Forex Payments, Mobile Phone Top-Ups, EGaming, Healthcare Payments, Esports, Invoice factoring, Online Travel, Vacation Resort, Blockchain Systems, and Fintech app sectors. Click here to read more.

For further information on RevoluGROUP Canada Inc. (TSX-V: REVO), visit the Company's website at

RevoluGROUP Canada, Inc.

"Bernard Lonis"
Bernard Lonis
Chairman of the Board & Director

For further information, contact:
RevoluGROUP Canada Inc.
Telephone: (604) 332 5355


This release includes certain statements that may be deemed to be "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that Management of the Company expects, are forward-looking statements. Although Management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. The Company undertakes no obligation to update these forward-looking statements if Management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause actual results to differ materially from those in forward-looking statements, include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see the public filings of the Company at for further information.

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye